FundedStartupsDaily / HealthTech / Commit Biologics

Commit Biologics raises €54M

Commit Biologics announced a Seed round of €54M on 17 November 2026. The company operates in HealthTech and is based in Denmark. It was founded by Thomas L. F. Montgomery Andresen, CEO. Announced 3 days ago.

Raised
€54M
Stage
Seed
Industry
HealthTech
Country
Denmark

Founder

Thomas L. F. Montgomery Andresen
CEO, Commit Biologics

Outreach angles

  • -Dr Thomas L. F. Montgomery Andresen was appointed CEO of Commit Biologics in March 2026.
  • -Andresen is taking COM002, a first-in-class immune engager that works independently of T cells, towards the clinic.
  • -The seed was led by Ackermans & van Haaren, with AbbVie Ventures and M Ventures joining Novo Holdings and other existing backers.

Signals

SeedDeep TechHealthcareRegulated Industry

Round details

Company: Commit Biologics
Domain: commitbio.com
Amount: €54M
Stage: Seed
Industry: HealthTech
Country: Denmark
Announced: 17 November 2026
Source: announcement

Other HealthTech raises

Recently funded in Denmark